Finance entity

Oppenheimer

Company

Coverage clusters in markets, which accounts for 5 of those 7, with the remainder spread across 2 other categories. Against the same-window beat baseline of 26% negative, this entity's 0% share is less negative. Morgan Stanley is the most frequent co-covered peer, appearing in 3 of the 7 tracked stories.

Last mentioned: 2d ago

RSS updates
Share

Entity pulse

Recent coverage · Oppenheimer

↑
7 stories
5.6 avg impact
14% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 14 percentage points.

  • 14% positive
  • 86% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Oppenheimer

Coverage clusters in markets, which accounts for 5 of those 7, with the remainder spread across 2 other categories. Against the same-window beat baseline of 26% negative, this entity's 0% share is less negative. Morgan Stanley is the most frequent co-covered peer, appearing in 3 of the 7 tracked stories. That works out to roughly 0.3 stories per week across a 183-day span. They are less corroborated than the beat average, carrying 2.3 original sources each against 2.7 for the same window. The 5.6 average consequence score is below the beat benchmark of 6.2 in the same window. We currently track 7 Finance stories that mention Oppenheimer, published between March 11, 2026 and September 9, 2026.

Stories tracked
7
Per week
0.3
Negative
0%
Sources per story
2.3

Computed from the 7 stories linked to this entity, with beat comparisons drawn from all 3197 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Oppenheimer. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Wells Fargo Cuts Target to $70

    Wells Fargo & Company lowers Freshpet’s price target from $75.00 to $70.00, keeping an Overweight rating, implying 28.42% upside.

  2. Bank of America Lowers Target

    Bank of America reduces its price target from $75.00 to $70.00 and maintains a Neutral rating.

  3. TD Cowen Sets Street-High $73 Target

    TD Cowen raised target from $63 to $73, the highest among all analysts, maintaining a Buy rating.

  4. Piper Sandler Stays Overweight

    Piper Sandler reaffirms an Overweight rating on Freshpet shares.

  5. Weiss Ratings Downgrades

    Weiss Ratings cuts Freshpet from 'Hold (c)' to 'Hold (c-)'.

  6. Morgan Stanley Revises Target to $51

    Morgan Stanley raised target from $38 to $51 but kept Equal Weight rating, signaling a cautious stance.

  7. Analyst Surge: Four Firms Raise Targets

    Oppenheimer, Goldman Sachs, KeyCorp, and Barclays all lifted price targets to the $55–$60 range, reiterating Buy/Outperform ratings.

  8. JPMorgan Upgrades, Others Reaffirm

    JPMorgan raises rating from Neutral to Overweight and lifts target from $66.00 to $68.00. Morgan Stanley reiterates Overweight with $77.00 target, while Deutsche Bank holds at Hold with $63.00 target.

  9. Jefferies Cuts Target

    Jefferies Financial Group lowers its price objective from $75.00 to $70.00 and maintains a Hold rating.

  10. TD Cowen Turns Bullish

    TD Cowen upgrades Freshpet from Hold to Buy and sets an $80.00 price objective.

  11. Oppenheimer Upgrades Freshpet

    Oppenheimer raises Freshpet from Market Perform to Outperform with an $80.00 price target.

  12. Zacks Downgrades to Hold

    Zacks Research downgraded Forgent Power Solutions to a Hold rating amid valuation concerns.

Stories mentioning Oppenheimer 7

Markets Neutral

MARA Up 4.6% at $11.83 and STRL Up 3.2%: Analyst Targets Slip

Tuesday's midday tape lifted MARA 4.6% to $11.83 and Sterling Infrastructure 3.2% to $502.20, but the more important signal for investors is a multi-week pattern of analyst price-target cuts. MARA's consensus target of $18.78 implies large upside yet carries 5.32 beta and negative earnings; STRL's $690.33 target still sits 37% above its price but below prior $900-plus targets. Finance readers should weigh consensus 'Moderate Buy' labels against balance-sheet and technical risks.

3 sources

Source: themarketsdaily.com · tickerreport.com

Oppenheimer is linked from 7 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.